1.
Biomed Environ Sci
; 36(10): 959-971, 2023 10 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37932064
2.
Mol Biol Rep
; 49(1): 755-759, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34825319
RESUMO
GTPase activating proteins (GAPs) were initially considered as the inhibitors of cell signaling pathways because of their nature to activate the intrinsic GTPase activity of the RhoGTPases. But recent studies of dysregulated GAPs in many cancers such as glioblastoma, colorectal cancer, breast cancer, and renal cancer have elucidated the important roles of GAPs in carcinogenesis and GAPs have been shown to perform multiple nonconventional functions in different contexts. We have discussed the recent developments in the roles played by different types of srGAPs (SLIT-ROBO Rho GTPase-activating proteins) in cancer.